Form Approved
OMB No. 0935-0191
Exp. Date 3/31/2015
Survey of Clinician Use of Information Resources for Making Patient Treatment Decisions
Conducted for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services Rockville, Maryland
| Public reporting burden for this collection of information is estimated to average 20 minutes per response, the estimated time required to complete the survey. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: AHRQ Reports Clearance Officer Attention: PRA, Paperwork Reduction Project (0935-0191) AHRQ, 5600 Fishers Lane, Rockville, MD 20857. |
Battelle Memorial Institute (Battelle) is conducting this survey on behalf of the Agency for Healthcare Research and Quality (AHRQ). AHRQ is a Federal agency under the US Department of Health and Human Services charged with improving the quality, safety, efficiency, and effectiveness of health care for all Americans.
The purpose of the survey is to learn how clinicians use health care information resources to make treatment decisions for their patients. The results of the survey will be used to inform AHRQ’s efforts to develop and disseminate unbiased, evidence-based information to patients, doctors, and others involved in health care decisionmaking.
Based on a proprietary list of all U.S. physicians compiled by the American Medical Association, we randomly selected approximately 2500 physicians to participate in this survey. You are being asked to participate in this survey because you were among the physicians selected.
Your participation in the survey is entirely voluntary. You can discontinue participation at any time. You can decline to answer any of the questions on the survey.
Completing the survey will take approximately 20 minutes. If you choose to participate, please fill out the questionnaire as completely and accurately as possible and return to Battelle in the postage-paid envelope provided in the survey packet. You will receive $50 in appreciation for your time and effort for this survey.
This survey is designed to benefit society by gaining new knowledge that will assist AHRQ’s efforts to develop and disseminate information for health care decisionmaking. You may not benefit personally from being in this research study.
Battelle will take several steps to maintain the confidentiality of survey participants. First, each survey participant will be assigned a unique identification number and names or any other personally identifying information will not be linked to survey responses. Second, we will not report the names and responses of individual participants to AHRQ or in any report or publication. Additionally, data provided to AHRQ at the completion of the study will not contain the names or any other personally identifying information.
If you have any questions about this study, please contact Dr. Judith Berkowitz (Battelle) at 1-866-846-9021. If you have any questions about your rights as a study participant, please call Dr. Margaret
Pennybacker, chair of Battelle’s Institutional Review Board, toll free at 1-877-810-9530, ext. 500.
By completing and returning the survey questionnaire, you are providing your consent to participate in this study.
This part of the survey asks questions that will let us describe the survey participants. Please write in or check (√) the best answer.
1. What is your age?
______years
2. What is your sex?
__ Male
__ Female
3. Are you Hispanic or Latino/Latina?
__ Yes
__ No
4. What is your race? (Please check √ all that apply.)
__ American Indian or Alaska Native
__ Asian
__ Black or African American
__ Native Hawaiian or other Pacific Islander
__ White
5. State of residence: (Please check √ only one.)
| __ AL |
__ IL |
__ MT |
__ RI |
| __ AK |
__ IN |
__ NE |
__ SC |
| __ AZ |
__ IA |
__ NV |
__ SD |
| __ AR |
__ KS |
__ NH |
__ TN |
| __ CA |
__ KY |
__ NJ |
__ TX |
| __ CO |
__ LA |
__ NM |
__ UT |
| __ CT |
__ ME |
__ NY |
__ VT |
| __ DE |
__ MD |
__ NC |
__ VA |
| __ DC |
__ MA |
__ ND |
__ WA |
| __ FL |
__ MI |
__ OH |
__ WV |
| __ GA |
__ MN |
__ OK |
__ WI |
| __ HI |
__ MS |
__ OR |
__ WY |
| __ ID |
__ MO |
__ PA |
|
6. Are you a: (Please check √ only one.)
__ Physician
__ Physician Assistant
__ Nurse Practitioner
__ Nurse
__ Pharmacist
__ Other (specify) ______________________________________
7. Since completing your medical training for the role you indicated in Question 6 (including residency and fellowship), how long have you been practicing medicine?
______ years
8. If you are a physician, what is your primary clinical specialty? (Please check √ only one.)
__ Family Medicine
__ General Internal Medicine
__ Obstetrics/Gynecology
__ Other – Please specify: ________________________________________________________________________
__ Not Applicable (“I am not a physician”)
9. If you are a physician, what is your clinical sub-specialty, if any?
____________________________________________________________________________________________
__ No clinical sub-specialty
10. Is your primary practice site located in one of the following? (Please check √ only one.)
__ Private practice office
__ Ambulatory care clinic of hospital/medical center
__ Urgent care clinic
__ Community health center
__ Public health clinic
__ Hospital emergency department
__ Institutional setting/clinic (e.g., correctional, nursing home)
__ Clinic that is part of a Health Maintenance Organization (HMO)
__ Academic or teaching hospital
__ Other type of clinic (Specify):
11. Please provide your best estimate for the total number of clinical staff in your department or unit at your primary practice site who provide direct care to patients. Include physicians, nurses, physician assistants, full-time and part-time, etc.
Number of clinical staff providing direct care: ______ ______ (Record number 0001-9999)
__ Don’t know/not sure
12. On average, how many hours per week do you spend on direct patient care?
________ HRS / WK
If you spend less than 8 hours per week on direct patient care, please STOP and return the survey in the postage-paid envelope.
13. In general, with how many patients, if any, do you share educational materials to help them make informed decisions about their treatment options? (Please check √ only one.)
__ I share materials with every patient
__ I share materials with most patients
__ I share materials with some patients
__ I rarely share materials with patients
__ I have never shared any fact sheets, summaries, or materials with my patients
__ Does not apply, I do not help patients make treatment decisions → Go to Question #16
14. When I do not discuss treatment options with my patients it is because… (Please check √ all that apply.)
__ I don’t have enough time
__ I don’t want to confuse my patients
__ My organization or practice doesn’t encourage my talking to patients about treatment options
__ My patients don’t seem interested in hearing about treatment options
__ My patients look uncomfortable when I discuss treatment options with them
__ My patients have difficulty understanding their treatment options
__ My patients are quickly overwhelmed by the amount of information
__ My patients are already aware of their treatment options
__ My patients expect me to know what is best for them
__ When there are not treatment options to discuss
__ Not applicable, I discuss options with every patient
__ None of the above
15. When I do discuss treatment options with my patients… (Please check √ all that apply.)
__ It is because my patients ask me for options
__ It is because my patients ask me about specific options
__ I tell them about the relative effectiveness of each option
__ I describe the potential cost of each option with them
__ I describe the risks and benefits of each option with them
__ I tell them about my experience with each option
__ None of the above
16. For many medical conditions, there are a variety of treatment options. Different treatments often have different levels of benefit and different levels of risk for side effects. Treatments can also differ on cost.
Have you ever heard about types of research that are designed to help you make treatment decisions with your patients by comparing the benefits and harms of different treatment options?
__ Yes → Go to Question #16a
__ No
__ Don’t know/not sure
16a. If you answered “Yes”, what is this type of research called?
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
_______________________________________________________________________________________________
17. How familiar are you with the following types of research that help you make treatment decisions based on comparisons of benefits and harms of different options?
| |
Not at all familiar / never heard of it |
Have heard the name but not familiar |
Somewhat familiar |
Mostly/Very familiar |
| a. Comparative effectiveness research (CER) |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
| b. Evidence-based medicine (EBM) |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
| c. Comparative treatments analysis (CTA) |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
| d. Health technology assessment (HTA) |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
| e. Patient-centered outcomes research (PCOR) |
__ 1
|
__ 2 |
__ 3 |
__ 4 |
| f. Risks-benefits research (RBR) |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
The next questions are about your awareness and understanding of comparative effectiveness research (CER), a type of patient-centered outcomes research (PCOR).
18. Comparative effectiveness research compares different health care interventions for common conditions by rigorously evaluating existing scientific literature and generates new findings through scientific studies of different treatment and diagnostic interventions.
Where, if ever, have you read or heard about comparative effectiveness research? (Please check √ all that apply.)
__ Nowhere – never heard of comparative effectiveness research → Go to Question #22
__ Article in a medical/science journal
__ Advertisement in journal or trade magazines
__ Web site
__ Conference or professional meeting
__ Colleagues
__ Employer
__ Advertisement on TV, radio, or in a store
__ Educational visit at your place of practice by a trained professional
__ Article in a newspaper or magazine or story on TV news
__ Through a continuing education course
__ Other (specify):
__ I’ve heard of it before, but don’t know where
19. In the table below, indicate whether or not each of the following statements reflects the principles and methods of comparative effectiveness research.
| |
Yes |
No |
Not Sure |
| a. Compares effectiveness and risks of established and emerging treatments |
__ 1 |
__ 2 |
__ 3 |
| b. Addresses treatments for common chronic medical conditions |
__ 1 |
__ 2 |
__ 3 |
| c. Includes reviews of existing scientific literature |
__ 1 |
__ 2 |
__ 3 |
| d. Includes new studies based on analyses of health care databases |
__ 1 |
__ 2 |
__ 3 |
| e. Includes new scientific studies testing the efficacy of specific new medical treatments or technologies |
__ 1 |
__ 2 |
__ 3 |
| f. Risks-benefits research (RBR) |
__ 1 |
__ 2 |
__ 3 |
| g. Intended to support informed decisionmaking |
__ 1 |
__ 2 |
__ 3 |
| h. Addresses treatments for acute medical conditions |
__ 1 |
__ 2 |
__ 3 |
| i. Identifies areas of clinical uncertainty and gaps in the scientific literature |
__ 1 |
__ 2 |
__ 3 |
| j. Intended to assist in shared decisionmaking between clinicians and individual patients |
__ 1 |
__ 2 |
__ 3 |
| k. Provides specific clinical practice recommendations for medical conditions |
__ 1 |
__ 2 |
__ 3 |
20. In the table below, please indicate the extent to which you agree or disagree with the following statements about comparative effectiveness research in clinical decisionmaking.
| Comparative effectiveness research…. |
Strongly Disagree |
Disagree |
Neither agree nor disagree |
Agree |
Strongly agree |
| a. Is neutral and unbiased |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| b. Is scientifically rigorous |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| c. Provides findings that are descriptive, not prescriptive |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| d. Provides objective information about drugs, medical equipment, and treatments |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| e. Provides findings that support informed decisionmaking |
__ 1
|
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| f. Highlights current evidence about effectiveness, risks, and side effects |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| g. Identifies areas of clinical uncertainty and gaps in the scientific literature |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| h. Includes confidence ratings on evidence in its reports, products, and materials |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| i. Helps me deliver better health care to my patients |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| j. In general, medical decisions based on comparative effectiveness research lead to better patient outcomes |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| k. Medical decisions based on comparative effectiveness research are more cost effective in the long run |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
| l. Leads to shared decisionmaking between clinicians and individual patients |
__ 1 |
__ 2 |
__ 3 |
__ 4 |
__ 5 |
21. Below, we present a pair of adjectives that could be used to describe opinions about comparative effectiveness research. For each pair of words, please check √ the box along the scale for each word pairing that describes your opinion of comparative effectiveness research. Selecting a box closer to the word on the left means that your opinion is closer to the word on the left. Selecting a box closer to the right means your opinion is closer to the word on the right.
For clinical decisionmaking, comparative effectiveness research is:
| Beneficial |
|
|
|
|
|
Not beneficial |
| Not helpful |
|
|
|
|
|
Helpful |
| Easy to understand |
|
|
|
|
|
Hard to understand |
| Objective |
|
|
|
|
|
Biased |
| Not credible |
|
|
|
|
|
Credible |
| Trustworthy |
|
|
|
|
|
Untrustworthy |
| Not valuable |
|
|
|
|
|
Extremely valuable |
22. How interested are you in learning more about comparative effectiveness research? (Please check √ only one.)
__ Not at all interested
__ Not very interested
__ Somewhat interested
__ Interested
__ Very interested
Return to Contents
Proceed to Next Section